Antidepressant therapy may lift more than just spirits Martin Gallagher Newsletter Article 15 February 2013 Pages: 3 - 4
New antirheumatic drugs: will they come from natural sources? Tracey Earl Newsletter Article 15 February 2013 Pages: 5 - 6
Interferon - does it have a role in hepatitis B and C? Newsletter Article 15 February 2013 Pages: 6 - 6
Prostaglandin inhibitors the only choice for preterm labour Newsletter Article 15 February 2013 Pages: 6 - 6
The time to banish the Hawksley sphygmomanometer is overdue Newsletter Article 15 February 2013 Pages: 7 - 7
Reviewing zidovudine from a pharmacoeconomic perspective Newsletter Article 15 February 2013 Pages: 8 - 8
What does it cost to develop a new drug? Richard Milne Newsletter Article 15 February 2013 Pages: 9 - 9
Moving closer to effective hepatitis delta vaccination Newsletter Article 15 February 2013 Pages: 10 - 10
Torasemide - the new choice for cirrhosis with ascites? Newsletter Article 15 February 2013 Pages: 13 - 13
Epoetin reduces transfusion needs in hip replacement Newsletter Article 15 February 2013 Pages: 14 - 14
Better response with clomipramine in obsessive-compulsive disorder Newsletter Article 15 February 2013 Pages: 16 - 16
Interferon alpha 2B in hepatitis - recent trial results Newsletter Article 15 February 2013 Pages: 18 - 18
Quinidine + amiodarone - effective for atrial fibrillation Newsletter Article 15 February 2013 Pages: 19 - 19
Ketorolac a beneficial addition to fentanyl analgesia Newsletter Article 15 February 2013 Pages: 19 - 19
Choline-L-alfoscerate improves Alzheimer’s dementia Newsletter Article 15 February 2013 Pages: 19 - 19
Hydroxychloroquine counters adverse effects of steroid therapy Newsletter Article 15 February 2013 Pages: 20 - 20
Switching to deflazacort improves growth in children Newsletter Article 15 February 2013 Pages: 20 - 20